Valencia, CA, United States of America

Michael Allen Faltys

This inventor holds 84 USPTO granted patents and 13 published patent applications and 8 EPO patents, primarily in Neural Stimulation (CPC class A61N1-37205). Top assignees: Advanced Bionics Corporation, Setpoint Medical Corporation, Advanced Bionics Ag. Active years: 1997-2025.

USPTO Granted Patents = 84 

% Patents Active = 79.8

 

Average Co-Inventor Count = 2.6

ph-index = 33

Forward Citations = 6,097(Granted Patents)

Forward Citations (Not Self Cited) = 5,240(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Northridge, CA (US) (1997 - 2018)
  • Valencia, CA (US) (2011 - 2024)

Company Filing History:


Years Active: 1997-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Neural Stimulation
Vagus Nerve Stimulation
Chronic Inflammation Treatment
Implantable Microstimulators
Batteryless Devices
Nerve Cuff
Cholinergic Pathway
Non-Invasive Stimulation
Bone Erosion Modulation
Cochlear Stimulation
Thermal Regulation
84 patents (USPTO):Explore Patents

Title: Michael Allen Faltys - Innovative Inventor from Valencia, CA

Introduction: Michael Allen Faltys is a renowned inventor based in Valencia, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Michael Allen Faltys holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovative ideas.

Career Highlights: Throughout his career, Michael Allen Faltys has been recognized for his ability to transform creative concepts into tangible inventions that have had a significant impact on the market.

Collaborations: Michael Allen Faltys has collaborated with leading companies, research institutions, and universities to further develop his inventions and bring them to the market successfully.

Conclusion: Michael Allen Faltys continues to inspire with his innovative spirit and dedication to creating solutions that shape the future across different sectors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…